MENU
AMLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Amylyx Pharmaceuticals (AMLX) Ownership - Who owns Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more
Profile
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
449.72M
P/E Ratio
2.69
Total Cash
204.07M
Projected Growth
N/A
Total Debt
1.38M
Revenue
-1.27M
Risk (Beta)
-0.68
Dividend Yield
N/A
Total Cash/Share
2.29
Total Debt/Equity
N/A
Revenue/Share
-0.02 USD as % of share price
Fundamentals
AMLX
Capitalization
450M
P/E Ratio
2.69
Risk (Beta)
-0.68
Dividend Yield
N/A
Total Cash
204M
Total Cash/Share
2.29
Total Debt
1.38M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
-0.02%
Revenue
-1.27M
ROE
N/A
Book Value
201M
P/B Ratio
2.23
Cash Flow
N/A
Earnings
-3.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
12.05
Current Revenue Per Employee
1083.33
Dividends Per Share - Security
N/A
EBITDA
-206.81M
Float
N/A
Float - Current
N/A
Gross Income Margin
-94.47
Revenue To Assets
-68.70
Shares Held By Institutions
291M
Shares Outstanding - Current
89.1M
Total Liabilities
18.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
34.921
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com